Cholesterol-Lowering Drugs Don’t Offset Healthy Choices

	Tweet

Within the medical field, it is often assumed that patients view cholesterol-lowering medications (or Statins) as a license to eat whatever they like—they figure their medication has them covered, so a steak here and there won’t hurt. However, a study published in the August issue of Mayo Clinic Proceedings finds that such patients don’t tend to adopt unhealthy diets when prescribed Statins.

Researchers also found that some patients were placed on cholesterol-lowering drugs before they’d made a good faith effort at improving their lifestyle to better their health. And some said they would have preferred starting with lifestyle alterations rather than medication.

Devin Mann, M.D., lead author of the article on statin use, says physicians should reconsider how they’re treating patients who seek preventive care for cardiovascular disease, namely by giving up their long-held assumptions about them.

“Physicians aren’t good at predicting patient behavior, so they should seek to form a partnership of trust with patients based on mutual respect and optimal communication,” says Dr. Mann from Mount Sinai School of Medicine.

This study involved 71 patients who had been prescribed Statins for the primary prevention of cardiovascular disease. Patients were interviewed at the time of prescription and three and six months later, when no significant change in saturated fat intake was noted.

Other authors of the report were John Allegrante, Ph.D., of Columbia University, New York; Sundar Natarajan, M.D., of New York University School of Medicine; Victor Montori, M.D., of Mayo Clinic; Ethan Halm, M.D., of Mount Sinai, New York; and Mary Charlson, M.D., of Cornell University, Ithaca, N.Y.

A peer-review journal, Mayo Clinic Proceedings publishes original articles, reviews and editorials dealing with clinical and laboratory medicine, clinical research, basic science research and clinical epidemiology. Mayo Clinic Proceedings is published monthly by Mayo Foundation for Medical Education and Research as part of its commitment to the medical education of physicians. The journal has been published for more than 80 years and has a circulation of 130,000 nationally and internationally. 

RELATED STORIES:
New advance announced in reducing ‘bad’ cholesterol   Cholesterol drugs safe, even after a decade of use   Green tea shows small effect on cholesterol   Cleveland Clinic researcher reports that evacetrapib can increase HDL (good) cholesterol 128 percent   Targeting cholesterol to fight deadly brain cancers   Astra’s Crestor drug fails to beat Pfizer’s Lipitor   Diet alone helps lower bad cholesterol: study   ‘Good’ cholesterol function as important as its levels   Super-sticky ‘ultra-bad’ cholesterol revealed in people at high risk of heart disease   ‘Good cholesterol’ structure identified, could help explain protective effects   Eggs are now naturally lower in cholesterol   Questions over statin prescribing

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]